GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Total Equity

Chi Sheng Pharma & Biotech Co (ROCO:4111) Total Equity : NT$1,275 Mil (As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Chi Sheng Pharma & Biotech Co Total Equity?

Chi Sheng Pharma & Biotech Co's total equity for the quarter that ended in Dec. 2024 was NT$1,275 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Chi Sheng Pharma & Biotech Co Total Equity Historical Data

The historical data trend for Chi Sheng Pharma & Biotech Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chi Sheng Pharma & Biotech Co Total Equity Chart

Chi Sheng Pharma & Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,075.79 1,100.74 1,222.15 1,219.06 1,274.55

Chi Sheng Pharma & Biotech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,219.06 1,242.18 1,205.77 1,225.95 1,274.55

Chi Sheng Pharma & Biotech Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Chi Sheng Pharma & Biotech Co's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1749.63-475.08
=1,275

Chi Sheng Pharma & Biotech Co's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1749.63-475.08
=1,275

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chi Sheng Pharma & Biotech Co Total Equity Related Terms

Thank you for viewing the detailed overview of Chi Sheng Pharma & Biotech Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Chi Sheng Pharma & Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Total Equity
Comparable Companies
ROCO:6543 ROCO:4150 ROCO:4116 ROCO:6527 ROCO:6730 ROCO:7575 ROCO:6518 ROCO:4115 ROCO:6493 TPE:4737 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM
Traded in Other Exchanges
N/A
Address
No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316
Website
http://www.cscp.com.tw
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.

Chi Sheng Pharma & Biotech Co Headlines

No Headlines